Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01732965 · ClinicalTrials.gov registry record · Phase 4
NB-UVB and PUVA Vitiligo Study
A Phase 4 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01732965 is a Phase 4 study that has completed, run by Henry Ford Health System. The registered enrollment target is 10 participants.
The verdict
NCT01732965, a Phase 4 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.
Interventions
- OTHER Phototherapy
- OTHER Phototherapy and Photochemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01732965
The ClinicalTrials.gov registry entry for NCT01732965 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phototherapy is the first listed.
NCT01732965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01732965 about?
NCT01732965 is a clinical study titled "NB-UVB and PUVA Vitiligo Study". To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.
What is the current status of trial NCT01732965?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01732965?
The interventions under investigation include: Phototherapy (OTHER), Phototherapy and Photochemotherapy (OTHER).
Who is sponsoring clinical trial NCT01732965?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.